Wealthcare Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Wealthcare Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-115	Closed	-$52K	–	607
2021 Q1	$52K	Buy	+115	New	+$54.9K	0.01%	135
2020 Q2	–	Sell	-19	Closed	-$5K	–	227
2020 Q1	$5K	Sell	19 -14	-42%	-$4.42K	﹤0.01%	177
2019 Q4	$11K	Buy	+33	New	+$10K	﹤0.01%	183
2015 Q2	–	Sell	-176	Closed	-$24K	–	816
2015 Q1	$24K	Buy	+176	New	+$22.7K	﹤0.01%	372

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealthcare Capital Management's TMO Position: Q2 2021 in Review

Wealthcare Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 115 shares — an estimated $52K sold.

Wealthcare Capital Management first reported a position in TMO in Q1 2015 and held it in 4 quarters. The position peaked at $52K in Q1 2021. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

Wealthcare Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
Wealthcare Capital Management sold 115 Thermo Fisher Scientific shares in Q2 2021, an estimated $52K.
Wealthcare Capital Management first reported a position in Thermo Fisher Scientific in Q1 2015 and held it in 4 quarters.
Wealthcare Capital Management's Thermo Fisher Scientific position peaked at $52K in Q1 2021.
2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.